학술논문

Pediatric hemophagocytic lymphohistiocytosis: A rarely diagnosed entity in a developing country
Document Type
Report
Source
BMC Pediatrics. September 18, 2021, Vol. 21 Issue 1
Subject
Colombia
Language
English
ISSN
1471-2431
Abstract
Background Hemophagocytic lymphohistiocytosis (HLH) is an exaggerated inflammatory reaction secondary to a host's inadequate immune response causing a self-perpetuating loop of altered regulation. Signs and symptoms of HLH are compatible with other common diseases and are nonspecific. Underdiagnosis makes it difficult to estimate the real incidence of HLH, especially in developing countries. Methods Retrospective, descriptive study of pediatric patients admitted to a high-complexity institution in Cali, Colombia between 2012 and 2019 with HLH diagnosis. Medical history review to complete an electronic database and a secondary, descriptive analysis was carried out. The study was approved by the Institutional Ethics Committee. Results Twenty-one patients were included. 52.4 % of the population was male with a median age of 9.3 years [IQR (3.0-13.7 years)]. More than half of patients (66.6 %) had viral disease at diagnosis, the most frequent being Epstein-Barr Virus (EBV) (52.3 %) and dengue (14.3 %). Three patients had confirmed gene mutations (G6PC3, XIAP, and UNC13D). 95 % of the patients were treated with the HLH 2004 protocol, half of them received incomplete protocol with intravenous immunoglobulin (IVIG) and/or systemic steroids, while the other half received the complete protocol including etoposide and cyclosporine. More than three-fourths (76.2 %) required admission to an ICU with a median stay of 14 days [IQR (11-37 days)] and a median hospital stay of 30 days [IQR (18-93 days)]. 14.3 % (n = 3) of patients died. Conclusions HLH is a complex disease that requires multidisciplinary management with secondary HLH due to EBV infection being a common cause. There is increasing awareness of HLH diagnosis in developing countries such as Colombia which can offer earlier treatment options and better outcomes. Keywords: Hemophagocytic, lymphohistiocytosis, pediatrics, Colombia, developing country
Author(s): Daniela Cleves[sup.1,2] , Viviana Lotero[sup.1,2,3] , Diego Medina[sup.1,2,4,5] , Paola M Perez[sup.1,2,4,6] , Jaime A Patiéo[sup.1,2,4,6] , Laura Torres-Canchala[sup.7] and Manuela Olaya[sup.1,2,4,8] Background Hemophagocytic lymphohistiocytosis (HLH) is an exaggerated [...]